Team

Leadership

Kinexar Bio was founded by a biopharmaceutical operator and a vaccine scientist — a pairing built for federal programs and commercial execution alike.

Devrim Aran

Co-Founder · President & Chief Executive Officer

Devrim Aran is an experienced biopharmaceutical executive and entrepreneur with a track record spanning drug development, regulatory strategy, clinical trials, and international licensing. He has led multiple biopharmaceutical ventures from inception through clinical development, securing government funding and building strategic partnerships across the United States and Europe. At Kinexar Bio, he leads all corporate, business development, and regulatory operations.

daran@kinexarbio.com

Dr. Omar Ahmed

Co-Founder · Chief Strategy Officer & Chief Scientific Officer

Dr. Omar Ahmed brings deep scientific expertise in vaccine platforms, immunology, and translational research to Kinexar Bio. He oversees scientific strategy, know-how transfer, and grant submissions including BARDA and NIH applications. His work bridges cutting-edge academic research and commercial drug development, ensuring the pAMP platform advances efficiently from preclinical studies toward regulatory milestones.

How We Work

A small team with federal-program discipline

Kinexar Bio operates lean and focused: one platform, one lead indication, and a development plan written against the standards that government reviewers and institutional investors both apply.

2
Co-founders leading corporate and scientific strategy
Delaware
State of incorporation, United States
US & EU
Partnership and licensing experience
BARDA · NIH
Active funding pathways pursued

Work with us

We are building relationships with scientific collaborators, government stakeholders, and investors aligned with biodefense preparedness.

Get in Touch Back to Top